Journalists Discuss New Alzheimer’s Drug, Women’s Alcohol Use, the Hip-Hop and Opioids Link

KHN chief Washington correspondent Julie Rovner discussed the FDA’s approval of a new drug for Alzheimer’s disease on WAMU’s “1A” on Wednesday.

• Click here to hear Rovner on WAMU

KHN correspondent Aneri Pattani discussed the increase in alcohol use and misuse by young women on NPR’s “All Things Considered” on Wednesday.

• Click here to hear Pattani on NPR
• Read Pattani’s “Women Now Drink as Much as Men — And Are Prone to Sickness Sooner”

KHN freelancer Harris Meyer discussed the FDA’s approval of a new drug for Alzheimer’s disease on Newsy on Tuesday and WCPN’s “The Sound of Ideas” on Wednesday.

• Click here to watch Meyer on Newsy
• Click here to hear Meyer on WCPN
• Read Meyer’s “FDA Weighs Approval of a Lucrative Alzheimer’s Drug, but Benefits Are Iffy”

KHN social media manager Chaseedaw Giles discussed opioid use and hip-hop music on NBC Lx’s “First Look” on Tuesday.

• Click here to watch Giles on NBC Lx
• Read Giles’ “Opioids Like ‘Lean’ Permeate Hip-Hop Culture, but Dangers Are Downplayed

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.